ReviewBiomolecules2026
Mas-Related G-Protein-Coupled Receptors: Emerging Roles in Neuropathic Pain.
Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Untangling neuropathic pain: pathophysiological insights and future directions for targeted therapy.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mas-related G-protein-coupled receptors constitute a distinct family of GPCRs expressed in some subsets of sensory neurons and immune cells. Increasing evidence highlights their contribution to the modulation of nociceptive signaling and neuroimmune interactions. Recent studies demonstrate that Mas-related G-protein-coupled receptors are implicated not only in itch transmission but also in the pathophysiology of neuropathic pain, where aberrant receptor activity influences neuronal excitability, glial activation, and inflammatory responses. This review summarizes current knowledge on the molecular mechanisms by which Mas-related G-protein-coupled receptors regulate pain hypersensitivity, including their interactions with ion channels, neuropeptides, and immune mediators. Moreover, the potential of targeting specific Mas-related G-protein-coupled receptor subtypes for therapeutic intervention is discussed, emphasizing their promise as novel druggable candidates for neuropathic pain, the emerging management. Clarifying the roles of Mas-related G-protein-coupled receptors in sensory modulation may provide critical insights into the development of mechanism-based analgesics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.